Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu, JL Li - OncoTargets and therapy, 2019 - Taylor & Francis
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …
被引用次数：48 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu - OncoTargets and Therapy, 2019 - pdfs.semanticscholar.org
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …

Comparative review of drug--drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.

ZY Xu, JL Li - OncoTargets and Therapy, 2019 - go.gale.com
The occurrence of drug--drug interactions (DDIs) is a serious problem for the use of
anticancer drugs. DDIs can exacerbate the risk of serious or fatal adverse events, and/or …

Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.

ZY Xu, JL Li - OncoTargets & Therapy, 2019 - search.ebscohost.com
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …
[PDF] scienceopen.com

[PDF][PDF] Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu - OncoTargets and Therapy, 2019 - scienceopen.com
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …

Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.

ZY Xu, JL Li - Oncotargets and Therapy, 2019 - europepmc.org
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …

Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu, JL Li - OncoTargets and Therapy, 2019 - hero.epa.gov
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …

Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu, JL Li - OncoTargets and Therapy, 2019 - dovepress.com
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …

Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu, JL Li - OncoTargets and therapy, 2019 - pubmed.ncbi.nlm.nih.gov
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …
[HTML] nih.gov

[HTML][HTML] Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

ZY Xu, JL Li - OncoTargets and therapy, 2019 - ncbi.nlm.nih.gov
The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the
epidermal growth factor receptor (EGFR) has revolutionized the management of non-small …